English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

By any immunology standards, scientists at the University of California San Francisco (UCSF) are embarking on a complicated research project—a $1 million study of organ transplants in HIV-infected patients. “Since the advent of highly active anti-retroviral therapy (HAART) for HIV infection about three years ago, patients' life expectancy has increased, leaving them susceptible to death from non-HIV-related causes, including end stage organ disease,” says project leader Peter Stock, explaining why transplants for such patients have become more feasible.

$1 million study renews HIV/transplant research